Suppr超能文献

三叉神经痛的插入式与“非接触式”转位微血管减压术的疗效比较

Outcome comparison between interposition and "contactless" transposition microvascular decompression approaches for trigeminal neuralgia.

作者信息

Lee Anthony T, Morshed Ramin A, Kondapavulur Sravani, Caldwell David J, Nichols Noah, Smith Genevieve, Wang Albert, Ward Mariann, Waung Maggie W, Winkler Ethan, Chang Edward F

机构信息

Departments of1Neurological Surgery and.

3Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York.

出版信息

J Neurosurg. 2025 May 30:1-12. doi: 10.3171/2025.2.JNS241831.

Abstract

OBJECTIVE

Microvascular decompression (MVD) is an effective method of treating trigeminal neuralgia (TN). The traditional approach is an interposition technique in which Teflon is placed between the nerve and offending vessel. However, recurrent TN pain has been attributed to the Teflon itself, its migration, inflammatory granuloma formation, or continued direct compression. Thus, transposition techniques in which the nerve is fully decompressed without any contact with the offending vessel or the Teflon have been described. In this study, the authors report their institutional experience with interposition and newer transposition techniques such as sling transposition.

METHODS

A retrospective chart review was performed on patients who had undergone MVD from July 2015 to March 2024. Demographic, surgical, and clinical variables were collected, including modified Barrow Neurological Institute (BNI) pain intensity scale scores. Clinical outcomes were assessed using univariate and multivariate regression, and propensity score matching (PSM) was employed to minimize inherent heterogeneity in the surgical cohorts.

RESULTS

Three hundred five patients underwent MVD for TN. Eighty-four patients underwent interposition; 139, transposition with Teflon (full decompression with no contact to the nerve); and 48, transposition using a pericranium sling to the tentorium. A subset of these patients underwent concurrent rhizotomy: 73% interposition cases, 15% Teflon transposition cases, 4% sling transposition cases. Rhizotomy alone was performed in 34 patients. Transposition primarily involved the superior cerebellar artery (90%) and was associated with severe compression and nerve indentation. There were no differences in BNI scores at the last follow-up or in complications among the treatment groups. The only significant predictor of pain freedom on multivariate analysis was MRI demonstrating clear compression (OR 2.49, 95% CI 1.147-5.404, p = 0.021). However, subgroup analyses of patients with at least 1 year of follow-up showed a trend for increased pain freedom (BNI scores I and IIIa) with the sling transposition technique at 1 year, which was statistically significant at the 2-year follow-up (1 year: sling 96.6%, Teflon 86.9%, interposition 81.1%, p = 0.053; 2 years: sling 100%, Teflon 87.5%, interposition 77.5%, p = 0.049). PSM cohort analysis showed that sling transposition patients had higher rates of pain-free outcomes (BNI scores I and IIIa) at the last follow-up than the Teflon transposition patients (93.1% vs 62.1%, respectively, p = 0.003).

CONCLUSIONS

Interposition and transposition techniques for MVD are both effective. The authors' midterm data suggest longer-term TN pain control with sling transposition. Further studies will need to confirm the durability of long-term pain freedom.

摘要

目的

微血管减压术(MVD)是治疗三叉神经痛(TN)的一种有效方法。传统方法是一种置入技术,即将特氟龙置于神经与致病血管之间。然而,复发性TN疼痛被归因于特氟龙本身、其移位、炎性肉芽肿形成或持续的直接压迫。因此,已经描述了一些移位技术,即在不与致病血管或特氟龙接触的情况下使神经完全减压。在本研究中,作者报告了他们在置入技术和诸如吊带移位等更新的移位技术方面的机构经验。

方法

对2015年7月至2024年3月接受MVD的患者进行回顾性病历审查。收集人口统计学、手术和临床变量,包括改良的巴罗神经学研究所(BNI)疼痛强度量表评分。使用单变量和多变量回归评估临床结果,并采用倾向评分匹配(PSM)来最小化手术队列中的固有异质性。

结果

305例患者因TN接受了MVD。84例患者接受了置入技术;139例采用特氟龙移位(完全减压且不接触神经);48例采用颅骨膜吊带移位至小脑幕。这些患者中有一部分同时接受了神经根切断术:73%的置入病例、15%的特氟龙移位病例、4%的吊带移位病例。34例患者仅接受了神经根切断术。移位主要涉及小脑上动脉(90%),并伴有严重压迫和神经压痕。各治疗组在最后一次随访时的BNI评分或并发症方面没有差异。多变量分析中疼痛缓解的唯一显著预测因素是MRI显示明确的压迫(OR 2.49,95%CI 1.147 - 5.404,p = 0.021)。然而,对至少随访1年的患者进行亚组分析显示,吊带移位技术在1年时疼痛缓解(BNI评分I和IIIa)有增加的趋势,在2年随访时具有统计学意义(1年:吊带96.6%,特氟龙86.9%,置入81.1%,p = 0.053;2年:吊带100%,特氟龙87.5%,置入77.5%,p = 0.049)。PSM队列分析显示,吊带移位患者在最后一次随访时无疼痛结果(BNI评分I和IIIa)的发生率高于特氟龙移位患者(分别为93.1%和62.1%,p = 0.003)。

结论

MVD的置入技术和移位技术均有效。作者的中期数据表明吊带移位可实现更长期的TN疼痛控制。需要进一步研究来证实长期疼痛缓解的持久性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验